Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Controlling pathological pain by adenovirally driven spinal production of the anti‐inflammatory cytokine, interleukin‐10

Milligan, Erin D., Langer, Stephen J., Sloane, Evan M., He, Lin, Wieseler‐Frank, Julie, O'Connor, Kevin, Martin, David, Forsayeth, John R., Maier, Steven F., Johnson, Kirk, Chavez, Raymond A., Leinwand, Leslie A., Watkins, Linda R.·2005·European Journal of Neuroscience

Abstract

Gene therapy for the control of pain has, to date, targeted neurons. However, recent evidence supports that spinal cord glia are critical to the creation and maintenance of pain facilitation through the release of proinflammatory cytokines. Because of the ability of interleukin‐10 (IL‐10) to suppress proinflammatory cytokines, we tested whether an adenoviral vector encoding human IL‐10 (AD‐h‐IL10) would block and reverse pain facilitation. Three pain models were examined, all of which are mediated by spinal pro‐inflammatory cytokines. Acute intrathecal administration of rat IL‐10 protein itself briefly reversed chronic constriction injury‐induced mechanical allodynia and thermal hyperalgesia. The transient reversal caused by IL‐10 protein paralleled the half‐life of human IL‐10 protein in the intrathecal space (t 1/2 ∼ 2 h). IL‐10 gene therapy both prevented and reversed thermal hyperalgesia and mechanical allodynia, without affecting basal responses to thermal or mechanical stimuli. Extra‐territorial, as well as territorial, pain changes were reversed by this treatment. Intrathecal AD‐h‐IL10 injected over lumbosacral spinal cord led to elevated lumbosacral cerebrospinal fluid (CSF) levels of human IL‐10, with far less human IL‐10 observed in cervical CSF. In keeping with IL‐10's known anti‐inflammatory actions, AD‐h‐IL10 lowered CSF levels of IL‐1, relative to control AD. These studies support that this gene therapy approach provides an alternative to neuronally focused drug and gene therapies for clinical pain control.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1460-9568.2005.04057.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 217

Metadata

Authors
Milligan, E. D., Langer, S. J., Sloane, E. M., He, L., Wieseler‐Frank, J., O'Connor, K., Martin, D., Forsayeth, J. R., Maier, S. F., Johnson, K., Chavez, R. A., Leinwand, L. A., & Watkins, L. R.
Venue
European Journal of Neuroscience
Publisher
Wiley
Published
2005-04
Volume
21
Issue
8
Pages
2136-2148
ISSN
  • 0953-816X (ISSN-L)
  • 1460-9568
OpenAlex
W2064462697
Cited by
217
References
5
FWCI
9.49
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Controlling pathological pain by adenovirally driven spinal production of the anti‐inflammatory cytokine, interleukin‐10. https://app.cochat.ai/papers/10.1111/j.1460-9568.2005.04057.x
The paper
Milligan, E. D., Langer, S. J., Sloane, E. M., He, L., Wieseler‐Frank, J., O'Connor, K., Martin, D., Forsayeth, J. R., Maier, S. F., Johnson, K., Chavez, R. A., Leinwand, L. A., & Watkins, L. R. (2005). Controlling pathological pain by adenovirally driven spinal production of the anti‐inflammatory cytokine, interleukin‐10. European Journal of Neuroscience. https://doi.org/10.1111/j.1460-9568.2005.04057.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.